65,437 trials
Diabetes Mellitus, Non-Insulin-Dependent
Primary: Hemoglobin A1c Measurement — 7.37; 7.50; 7.49; 7.33 percent HbA1c
Advanced Cancer
Primary: Number of Participants With Clinically Meaningful Prolongation of the QT Interval Corrected for Heart Rate (QTc) From Time-matched Baseline — 0 Participants
Diabetes Mellitus, Type 2
Primary: Hemoglobin A1c (A1C) Changes From Baseline at Week 24 — 7.91; 7.98; 7.85; 7.88 Percentage of glycosylated hemoglobins — p=<.0001
Neuropathy, Diabetic
Primary: Change From Baseline in the Mean 24-hour Average Pain Intensity (API) Score at End of Maintenance Treatment (EOMT) Using Last Observation Carried Forward (LOCF) Data…
Healthy
Primary: Maximum Plasma Concentration (Cmax) — 3.087; 2.616 ng/mL
Restless Legs Syndrome
Primary: Change From Baseline in IRLS Rating Scale Total Score at Week 12 Using Last Observation Carried Forward (LOCF) — -9.8; -13.0 scores on a scale — p=0.0015
Pulmonary Embolism · Venous Thromboembolic Disease
Primary: Technical Success (Retrieval) — 58 participants
Diabetic Nephropathy · Type 2 Diabetes Mellitus · Proteinuria
Primary: Renal Composite Outcomes — 116; 129 participants — p=0.79
Primary Hypercholesterolemia and Homozygous Familial Hypercholesterolemia (HoFH)
Primary: Percentage of Participants With Any Clinical and/or Laboratory Adverse Experiences While Taking VYTORIN® Within 14 Days After Treatment Discontinuation — 5.72 Percentage…
Buprenorphine · Naloxone · Opiate-related Disorders
Primary: Number of Patients Reporting Misuse (Injection, Sniffing, Dose Fractionation, Modification of Prescribed Doses, and Combination With Psychotropic Agents) — 131; 20; 15…
Kidney Transplantation · Graft Rejection
Primary: Number of Participants With Composite Efficacy Endpoints - 12 Month Analysis — 75; 60; 70; 8 Participants
Influenza
Primary: Number of Participants Age 18 to 64 Years With a Serum Hemagglutination Inhibition Assay (HAI) Antibody Titer of 1:40 or Greater Against the H1N1 2009 Virus 21 Days…
Rib Fracture · Flail Chest
Primary: Adverse Post-op Events Related to the Repair and Plating System — 1; 3 Participants — p=0.190
Vasomotor Rhinitis
Primary: Mean Change in 2-week rTNSS From Baseline — 5.9; 6.5 Units on a scale
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Spirometry Parameter: Peak Forced Expiratory Volume in 1 Second(FEV1)in Liters (L) — 1.707; 1.696; 1.672; 1.676 Liters — p=<0.0001